Authors
Latest:
Advancing Brain Capital: Achievements, Lessons, and Next StepsA transdisciplinary team summarizes key points and reflections after 18 months of activity.
Latest:
Telling Humanity’s Brain Story: Insights From Brain CapitalWhich innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Latest:
History of Psychiatry: Its Relevance in Training and BeyondHere are 5 reasons why we need to study the history of psychiatry.
Latest:
Recovery-Oriented Cognitive Therapy: A Game Changer for Justice-Involved Individuals"CT-R emphasizes the importance of hope while taking it a step further, turning hope into meaningful action and internalizing what success says about a person’s identity, strength, and ability to navigate future challenges."
Latest:
MDMA-Assisted Therapy for PTSD: A Conversation With Amy Emerson, CEO of Lykos TherapeuticsIf approved, how will MDMA-assisted therapy impact clinical psychiatry? The CEO of Lykos Therapeutics shares her thoughts.
Latest:
Recognizing the Contributions and the Struggles of Black Psychiatrists“It is of the utmost importance to provide culturally competent forensic psychiatric services that are better suited to the needs of the African American community.”
Latest:
Integrating Digital Therapeutics Into Care of Serious Mental IllnessHow can digital therapeutics more readily be brought into the hands of patients with serious mental illnesses?
Latest:
Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive CarePanelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.
Latest:
Clinical Pearls: Inside the Mind of the AthleteWith the Super Bowl highlighting elite athletic performance, sports psychiatry is essential in strengthening athletes' mental resilience and well-being.
Latest:
Medical Aid in Dying and the “Slippery Slope” ArgumentAn expert offers a critical examination of the "slippery slope" argument.
Latest:
Alto Neuroscience Presents Key Data, Study Findings on ALTO-300Learn more about Alto Neuroscience's ALTO-300, in ongoing phase 2b trials as an adjunct treatment for major depressive disorder.
Latest:
Driving Advances in Drug Discovery for Mental Health ConditionsUnderstanding and addressing the unmet therapeutic needs of individuals living with mental health conditions.
Latest:
Dietary Interventions for ADHD: Emerging Research and ConsiderationsWhat is the connection between ADHD diagnosis and a Western dietary pattern?
Latest:
The Urgent Need to Address Youth Mental HealthIn this 2-part Special Report, we highlight the urgency of addressing child and adolescent mental health.
Latest:
The Cutting Edge of Medicine: An Interview With Alejandro Alva, MDIn advance of the June 4 FDA Advisory Committee Meeting on MDMA-assisted therapy, we sat down with Alejandra Alva, MD, to get his first impressions.
Latest:
The Role of Technology in Addressing Isolation of Older AdultsSeniors living independently have suffered isolation during the pandemic. What role can technology play in solving this?
Latest:
Vulnerability to Financial Scamming: Victim and Family ProtectionWith the growing elderly population and the prevalence of cognitive impairment, how can we protect older adults from financial scams?
Latest:
Cannabis and Schizophrenia: Implications in the Legalization EraA look at the association between cannabis use and schizophrenia, as well as the need for comprehensive public health policies and education.
Latest:
Augmentation Strategies for Treatment-Resistant DepressionGiven that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.
Latest:
Psychiatrists Call for End to Cruel and Harmful Immigration PolicyThe Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
Latest:
The Vanishing White CoatIf Roe v Wade is overturned, how will patients with serious mental illness be affected?
Latest:
The Faces of MadnessIf a picture is worth a thousand words, how many diagnoses can it make? The photographer and psychiatrist Hugh Welch Diamond, MD, shares insights into the humanity and stigma of mental illness in Victorian England.
Latest:
Exploring Vital Amines: The Who, What, When, Where, Why, and How of B12 DeficiencyKey nutrients are essential to maintaining health. Here's an overview of B12.
Latest:
Interest Grows in Treatment of Mood Disorders by Classic PsychedelicsClassic psychedelic research is rapidly expanding...
Latest:
Agree to Disagree: A Collaborative Perspective From a Treatment Team and Disagreeing PatientHow should clinicians approach treatment when their patient disagrees with the diagnosis?
Latest:
Cannabis in Pregnancy – Rejoinder, Exposition and Cautionary TalesCannabis use during pregnancy is associated with a host of negative outcomes.
Latest:
Developing Your Skills at the Intersection of Work and PsychiatryHere’s how the Academy of Organizational and Occupational Psychiatry can help you connect with your fellow psychiatrists about complex mental health issues in the workplace.
